Satio Receives Funding From ARPA-H to Develop SatioRx™ a Novel At-home, Remotely Controllable Transdermal Drug Delivery Device

BOSTON, Sept. 26, 2023 /PRNewswire/ — Satio is pleased to announce a $3.5 million Small Business Innovation Research (SBIR) contract awarded by the Advanced Research Projects Agency for Health (ARPA-H), National Institutes of Health, Department of Health and Human Services. This SatioRx™ device is designed to be compact and inexpensive, with disposable microneedle components that allow health care providers to remotely […]

Satio partners with BARDA DRIVe to develop a novel patch-based ebolavirus diagnostic

Satio is pleased to announce a contract awarded by the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services to develop a novel, single-use, rapid ebolavirus diagnostic.  This groundbreaking diagnostic will combine Satio’s patch-based blood collection device with Institut […]